Umeclidinium/Vilanterol Overview
9 Questions
100 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What classification does Umeclidinium / Vilanterol fall under?

  • Bronchodilator (correct)
  • Antihistamine
  • Combination Drug (correct)
  • Antibiotic

    • What are the trade names for Umeclidinium / Vilanterol?

    Anoro, Ellipta

    What route is used to administer Umeclidinium / Vilanterol?

    DPI

    What is the dosage and frequency for Umeclidinium / Vilanterol?

    <p>62.5 mcg / 25 mcg (1 inhalation) QD</p> Signup and view all the answers

    What is the primary action of Umeclidinium / Vilanterol?

    <p>Bronchodilation</p> Signup and view all the answers

    What is Umeclidinium / Vilanterol used for?

    <p>COPD related bronchospasms</p> Signup and view all the answers

    What is the duration of action for Umeclidinium / Vilanterol?

    <p>24 hours</p> Signup and view all the answers

    What is the onset of action for Umeclidinium / Vilanterol?

    <p>5-15 minutes</p> Signup and view all the answers

    Some side effects of Umeclidinium / Vilanterol include sore throat, muscle spasms, sinusitis, and __________.

    <p>respiratory tract infection</p> Signup and view all the answers

    Study Notes

    Umeclidinium / Vilanterol Overview

    • This drug is a combination medication classified as a bronchodilator.
    • Common trade names include Anoro and Ellipta.

    Administration and Dosage

    • Delivered via a dry powder inhaler (DPI).
    • Prescribed dosage is 62.5 mcg of Umeclidinium and 25 mcg of Vilanterol, administered as one inhalation daily.

    Mechanism of Action

    • The primary action is bronchodilation, which helps to open airways in the lungs.

    Indications for Use

    • Specifically used for treating COPD-related bronchospasms, improving airflow and breathing.

    Pharmacokinetics

    • The duration of action is approximately 24 hours, allowing for once-daily dosing.
    • Onset of action occurs within 5 to 15 minutes after administration, providing quick relief.

    Potential Side Effects

    • Common side effects include sore throat, muscle spasms, sinusitis, and respiratory tract infections.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Explore the essential information about Umeclidinium and Vilanterol, a combined bronchodilator used in COPD management. This quiz covers administration, dosage, mechanism of action, and potential side effects. Test your knowledge on this medication's therapeutic use and pharmacokinetics.

    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser